Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs103294
rs103294 		0.730 GeneticVariation BEFREE Three SNPs-rs2735839, rs10486567, and rs103294-were associated with biopsy-proven high-aggressive (GS ≥8) prostate cancer (P < 0.05). 25274378

2014
dbSNP: rs5945572
rs5945572 		0.730 GeneticVariation BEFREE Five SNPs showed independent associations with prostate cancer progression (rs12621278, rs629242, rs9364554, rs4430796, and rs5945572) based on stepwise regression analysis. 20651075

2010
dbSNP: rs5945572
rs5945572 		A 0.730 GeneticVariation GWASCAT Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). 18264098

2008
dbSNP: rs5945572
rs5945572 		0.730 GeneticVariation BEFREE Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). 18264098

2008
dbSNP: rs5945572
rs5945572 		0.730 GeneticVariation BEFREE Two single nucleotide polymorphisms (SNP; rs5945572 and rs5945619) at Xp11 were recently implicated in two genome-wide association studies of prostate cancer. 19549809

2009
dbSNP: rs10896449
rs10896449 		0.720 GeneticVariation BEFREE Three of the 23 genetic variants explored were nominally associated with prostate cancer progression; rs9364554 (P = 0.041) on chromosome 6q25 and rs10896449 (P = 0.029) on chromosome 11q13 among patients treated with curative intent; and rs4054823 (P = 0.008) on chromosome 17p12 among patients on surveillance. 21520160

2012
dbSNP: rs10896449
rs10896449 		0.720 GeneticVariation BEFREE We found evidence of prostate cancer association for the previously implicated SNPs including rs10896449, which we termed locus 1. 19505914

2009
dbSNP: rs10896449
rs10896449 		G 0.720 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015
dbSNP: rs10896449
rs10896449 		G 0.720 GeneticVariation GWASCAT Multiple loci identified in a genome-wide association study of prostate cancer. 18264096

2008
dbSNP: rs11986220
rs11986220 		0.720 GeneticVariation BEFREE For northern Chinese men rs16901966, rs1447295, rs11986220 and rs10090154 at 8q24 (region 1, region 2) are associated with prostate cancer and prostate cancer related clinical covariates. 22099997

2012
dbSNP: rs11986220
rs11986220 		0.720 GeneticVariation BEFREE Two enhancers in one risk region were occupied by AR and responded to androgen treatment; one contained a single nucleotide polymorphism (rs11986220) that resides within a FoxA1 binding site, with the prostate cancer risk allele facilitating both stronger FoxA1 binding and stronger androgen responsiveness. 19680443

2009
dbSNP: rs11986220
rs11986220 		A 0.720 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015
dbSNP: rs7679673
rs7679673 		C 0.720 GeneticVariation GWASCAT Two susceptibility loci identified for prostate cancer aggressiveness. 25939597

2015
dbSNP: rs7679673
rs7679673 		0.720 GeneticVariation GWASCAT Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. 19767753

2009
dbSNP: rs7679673
rs7679673 		A 0.720 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs7679673
rs7679673 		C 0.720 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018
dbSNP: rs7679673
rs7679673 		0.720 GeneticVariation BEFREE Two SNPs, rs2735839 at chromosome 19q13 and rs7679673 at 4q24, were associated with prostate cancer-specific survival (P = 7 × 10(-4) and 0.014, respectively). 21367958

2011
dbSNP: rs7679673
rs7679673 		0.720 GeneticVariation BEFREE SNP rs7679673, ~6.3kb upstream of TET2 and previously reported to be associated with prostate cancer risk, was associated with endometrial cancer risk in the direction opposite to that for prostate cancer [meta-analysis odds ratio = 0.87 (per copy of the C allele), 95% confidence interval = 0.81, 0.93; P = 7.37×10(-5)] with no evidence of heterogeneity across studies (P heterogeneity = 0.66). 24832084

2014
dbSNP: rs7679673
rs7679673 		C 0.720 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015
dbSNP: rs2660753
rs2660753 		T 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs2660753
rs2660753 		T 0.710 GeneticVariation GWASCAT Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008
dbSNP: rs2660753
rs2660753 		T 0.710 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018
dbSNP: rs2660753
rs2660753 		0.710 GeneticVariation BEFREE Although rs2660753 is a strong prostate cancer susceptibility polymorphism, the association with another hormonally related cancer, invasive EOC, is not supported by this replication study. 21415361

2011
dbSNP: rs4775302
rs4775302 		0.710 GeneticVariation GWASCAT We found significant associations between aggressive prostate cancer and five single nucleotide polymorphisms (SNPs) in the 10q26 (rs10788165, rs10749408, and rs10788165, p value for association 1.3 × 10(-10 ) to 3.2 × 10(-11) ) and 15q21 (rs4775302 and rs1994198, p values for association 3.1 × 10(-8 ) to 8.2 × 10(-9)) regions. 22130093

2011
dbSNP: rs4775302
rs4775302 		0.710 GeneticVariation BEFREE We found significant associations between aggressive prostate cancer and five single nucleotide polymorphisms (SNPs) in the 10q26 (rs10788165, rs10749408, and rs10788165, p value for association 1.3 × 10(-10 ) to 3.2 × 10(-11) ) and 15q21 (rs4775302 and rs1994198, p values for association 3.1 × 10(-8 ) to 8.2 × 10(-9)) regions. 22130093

2011